Related Experiment Video
Updated: Apr 25, 2026
05:08
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
1.3K
Onychomycosis: updates and management challenges. A review
The Nigerian Postgraduate Medical Journal
|August 30, 2014
Summary
Onychomycosis, a fungal nail infection, is a significant public health concern impacting patient quality of life. Management involves counseling, patient education, and often combination therapy for fungal nail disease.
Area of Science:
- Dermatology
- Mycology
- Public Health
Background:
- Onychomycosis is a fungal infection of the nail unit.
- Previously considered cosmetic, it's now a public health issue due to quality of life impacts.
- Risk factors include age, immunosuppression, occupation, and genetics.
Purpose of the Study:
- To review the epidemiology, clinical presentations, diagnostic methods, and current management strategies for onychomycosis.
- To highlight the importance of patient counseling and education in managing fungal nail infections.
- To discuss the role of combination therapy in treating onychomycosis.
Main Methods:
- This study is a comprehensive literature review.
- It synthesizes information on the epidemiology, clinical features, and investigations of onychomycosis.
- Current pharmacological and non-pharmacological treatment considerations are analyzed.
Main Results:
- Onychomycosis affects patient quality of life and is influenced by various risk factors.
- Effective management requires thorough pretreatment counseling on therapy duration, side effects, costs, and realistic expectations.
- No single treatment guarantees 100% effectiveness.
Conclusions:
- Combination therapy is currently advocated for managing onychomycosis.
- Patient education on proper nail care and treatment limitations is crucial.
- Understanding the multifaceted nature of onychomycosis is key to improving patient outcomes.
Related Concept Videos
01:15Antifungal Agents
114
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
114
01:23Skin Diseases and Disorders
5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
01:18Endocarditis III: Medical Management
359
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
359
01:26Nephrotic Syndrome II : Assessment and Medical Management
406
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
406
01:24Cystic Fibrosis: Management
653
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
653
01:29Endocarditis IV: Nursing Management
627
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
627